News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiaGenic ASA: Notice of Allowance of Breast Cancer Patent in Japan



8/3/2012 10:33:56 AM

OSLO, Norway--(BUSINESS WIRE)--DiaGenic has received notice of allowance of the family 3 patent application in Japan ( 2007-514130). The claims allowed cover the use of some important gene sequences in blood sample for detection and monitoring of breast cancer. The patent will be valid until 2025. Family 3 patents have earlier been granted in US and Europe.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES